Indefinite Delivery Contract 75D30123D18248
- The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division. With a potential value of $86M and a period of performance through September 2028, this contract will provide clinical immunization safety assessment services to the CDC. A $305K delivery order was also awarded against this contract to Columbia University for services from September 2023...
- The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery indefinite quantity contract to The Johns Hopkins University on September 26, 2023. With a potential value of $86 million and a period of performance through September 2028, this contract provides clinical immunization safety assessment services. Specifically, the 2023 Clinical Immunization Safety Assessment Base IDIQ aims to procure immunization safety research and consultation. A $954,643 delivery order...
- The Centers for Disease Control and Prevention awarded Vanderbilt University Medical Center an indefinite delivery contract with a potential value of $86 million to provide Clinical Immunization Safety Assessment base services from September 2023 through September 2028. Under this multiple award contract vehicle, VUMC will support CDC's immunization safety monitoring and vaccine safety research efforts. CDC also issued a $6.6 million delivery order to VUMC for Clinical Immunization Safety...
- The Centers for Disease Control and Prevention awarded an indefinite-delivery/indefinite-quantity contract to Children's Hospital Medical Center, doing business as Children's Home Healthcare, to provide Clinical Immunization Safety Assessment base services. The multiple award contract has a potential value of $86 million with a period of performance from September 2023 through September 2028. Two cost-no-fee delivery orders were also awarded for $1.1 million and $900,000 respectively, with...
- The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Contract (IDC) to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) base services. The $86,008,000.12 multiple-award IDC has a period of performance running through September 2028. Under this IDC, the CDC has issued two cost-no-fee delivery orders to Duke University totaling $3,053,131. The first order, valued at $875,045, covers CISA base...
- This Blanket Purchase Agreement (BPA) contract, awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency of the U.S. Department of Health and Human Services, to Emory University, a private research institution located in Atlanta, Georgia, is for the provision of various biological products and services. The contract, with a cumulative ceiling value of $2,000,000, includes individual task orders for the supply of biologicals, blood draw services, and COVID-19 blood...
- The Johns Hopkins University has been awarded a single-award indefinite delivery contract (IDC) by the Centers for Disease Control and Prevention (CDC) to provide clinical immunization safety assessments and consultation services. The $86 million contract has a period of performance from 2023 to 2028. Under this contract, Johns Hopkins will deliver task orders to support the CDC's mission of advancing public health through national immunization programs. A $954,643 delivery order details the...
- The Centers for Disease Control and Prevention awarded Boston Medical Center Corporation an indefinite delivery contract with a potential value of $86 million to provide Clinical Immunization Safety Assessment services. The base IDIQ establishes terms and conditions for future delivery orders related to immunization safety assessments to support the Department of Health and Human Services. Two initial cost-no-fee delivery orders totaling $1.9 million have been issued against the IDIQ. The first,...
- Duke University Office of Research Administration Division was awarded a multiple-award indefinite delivery/indefinite quantity (IDIQ) contract from the Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) program. The contract has a potential value of $200,000,000 and a period of performance through September 29, 2021. As the prime contractor, Duke University is providing clinical research and...
- This multiple award indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Emory University. With a potential value of $99 million and a period of performance from September 2021 through September 2026, this IDV aims to procure research and development services under the Safe Healthcare, Epidemiology, and Prevention Research Development Program. Specifically, the IDV falls under SHEPHERD Domain 3 and will...
- 75D30123D18248Indefinite Delivery Contract
- 3Federal Contract Awards
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Emory University for clinical immunization safety assessment services. The contract has a potential value of $86 million and a period of performance from September 2023 through September 2028. No set-aside was used. Under this contract, Emory University has received two cost-no-fee delivery orders to provide clinical immunization safety assessment support to the CDC. The first delivery order, valued at $1 million, has a period of performance from September 2023 through September 2028. The second delivery order, valued at $983,726, has a period of performance from September 2023 through September 2026. Both require all work to be performed in Atlanta, Georgia. The delivery orders were awarded to assist the CDC in monitoring vaccine safety through the Clinical Immunization Safety Assessment program. This program evaluates vaccine safety issues and provides medical and scientific consultation to address vaccine-associated adverse events.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/26/23 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75D30123D18248-75D30124F00003 | Emory University | $781.6k | 9/27/24 | 9/26/27 | 9/20/24 | |
Delivery Order 75D30123D18248-75D30123F00002 | Emory University | $983.7k | 9/27/23 | 9/27/26 | 9/27/23 | |
Delivery Order 75D30123D18248-75D30123F00001 | Emory University | $1.0m | 9/28/23 | 9/27/26 | 9/24/25 |